UK markets open in 1 hour 10 minutes

NexImmune, Inc. (NEXI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.1600+0.0700 (+2.27%)
At close: 04:00PM EDT
3.2100 +0.05 (+1.58%)
After hours: 07:18PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-25,857
-32,344
-62,506
-50,902
-29,866
-
Depreciation & amortisation
876.119
1,025
994.792
870.285
618.99
-
Stock-based compensation
3,059
3,554
5,870
5,980
1,217
-
Change in working capital
-1,127
-4,878
3,929
654.57
-89.431
-
Accounts payable
121.044
-1,041
1,387
-1,003
702.472
-
Other working capital
-21,568
-31,479
-52,446
-48,135
-27,269
-
Other non-cash items
2,306
537.406
500.553
903.919
1,272
-
Net cash provided by operating activities
-21,562
-31,430
-51,191
-45,785
-26,405
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-48.72
-1,255
-2,350
-864.659
-
Purchases of investments
-
0
-21,510
-90,457
0
-
Sales/maturities of investments
-
0
73,000
39,000
1,006
-
Other investing activities
-
-
-
-
80.224
9.905
Net cash used for investing activities
520.783
-44.492
50,316
-53,807
221.936
-
Cash flows from financing activities
Debt repayment
-
-
0
-12.26
-19.888
-18.437
Common stock issued
3,144
0
5,145
114,722
0
-
Other financing activities
-
-
-
-19.137
-363.764
-
Net cash used provided by (used for) financing activities
3,144
0
5,179
124,888
22,085
-
Net change in cash
-17,897
-31,475
4,303
25,295
-4,098
-
Cash at beginning of period
22,370
34,697
30,394
5,099
9,196
-
Cash at end of period
4,473
3,222
34,697
30,394
5,099
-
Free cash flow
Operating cash flow
-21,562
-31,430
-51,191
-45,785
-26,405
-
Capital expenditure
-
-48.72
-1,255
-2,350
-864.659
-
Free cash flow
-21,568
-31,479
-52,446
-48,135
-27,269
-